Blood tests could predict brain cancer survival
NCT ID NCT07417774
Summary
This study is testing if simple blood tests can help doctors better understand and predict how patients with a serious brain cancer (glioblastoma) respond to treatment. It involves 40 patients who are already part of a larger trial testing an experimental oxygen-boosting drug. The main goal is to find markers in the blood that show if the tumor is low on oxygen or if a scan shows real cancer growth versus treatment side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA (GBM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center for Neurosciences
Tucson, Arizona, 85718, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Saint Luke's Cancer Institute
Kansas City, Missouri, 64111, United States
-
Yale Cancer Center
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.